MAGPRED-40 Injection contains Methylprednisolone Sodium Succinate equivalent to Methylprednisolone 40 mg, a corticosteroid (glucocorticoid) formulation used to help reduce inflammation and suppress excessive immune responses.
Methylprednisolone works by modifying the body’s inflammatory and immune response. The injectable formulation is intended for I.V. or I.M. administration when systemic corticosteroid therapy is medically indicated.
MAGPRED-40 Injection may be used in hospital and clinical settings for various inflammatory, allergic, immune-mediated, and other conditions requiring corticosteroid treatment, as determined by a qualified healthcare professional.
Composition
- Methylprednisolone Sodium Succinate
- Equivalent to Methylprednisolone 40 mg
- Dosage form: Injection
- Route: I.V./I.M.
Indications / Uses
MAGPRED-40 Injection may be used when systemic corticosteroid therapy is indicated for:
- Severe allergic and hypersensitivity reactions
- Inflammatory and rheumatic conditions
- Autoimmune and collagen disorders
- Respiratory inflammatory conditions
- Dermatological inflammatory conditions
- Certain gastrointestinal and hematological disorders
- Other conditions requiring systemic corticosteroid therapy
Key Benefits
- Helps reduce inflammation
- Helps suppress excessive immune responses
- Provides systemic corticosteroid therapy
- Suitable for I.V. and I.M. administration
- Useful when injectable corticosteroid treatment is clinically indicated
- Suitable for hospital and clinical use under medical supervision
Important: MAGPRED-40 Injection is a prescription corticosteroid and should be administered only by a qualified healthcare professional. Dosage and duration depend on the patient’s condition and clinical response. Prolonged or inappropriate corticosteroid use may cause significant side effects.
